Amgen And The Institute For Protein Design (IPD) At University Of Washington Announce Unique Strategic Research Partnership

Collaboration Will Apply IPD's de novo Protein Design Expertise to Biotech Drug Discovery THOUSAND OAKS, Calif. and SEATTLE, June 19, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and the University of Washington's Institute for Protein Design (IPD), which is revolutionizing its field of science by creating custom-designed proteins from scratch to improve human health, today announced a broad collaboration that will cover multiple projects with a goal of testing new technologies and creating protein-building approaches that can be broadly applied to the search for new medicines. Under the terms of the agreement, Amgen has provided initial funding for three sponsored research projects ...
Source: Amgen News Release - Category: Pharmaceuticals Tags: Uncategorized Source Type: news